Table 2.
Evaluation of basic biochemical parameters in patients with severe obesity and metabolic syndrome and in the control group
| OB1 (n = 40) | CG (n = 15) | p | |
|---|---|---|---|
| Fasting glucose (mg/dl)a | 89; 67–124 | 90; 81–102 | NS |
| Fasting insulin (µIU/ml)a | 14.07; 5.45–56.33 | 6.81; 3.57–12.73 | <0.0001 |
| HOMAa | 3.31; 1.14–11.68 | 1.61; 0.78–3.02 | <0.0001 |
| Glucose level 2 h after OGTT (mg/dl)a | 109.58 ± 31.16 | 95.27 ± 24.14 | NS |
| Insulin level 2 h after OGTT (µIU/ml)a | 46.53; 6.23–273.1 | 19.22; 7.21–52.56 | 0.001 |
| HbA1C (%)a | 5.65; 5.20–10.90 | 5.60; 5.30–5.80 | 0.001 |
| Creatinine (mg/dl)b | 0.76 ± 0.16 | 0.77 ± 0.08 | NS |
| Total cholesterol (mg/dl)b | 199.15 ± 35.13 | 184.07 ± 28.68 | NS |
| HDL-chol (mg/dl)b | 52.55 ± 10.97 | 69.53 ± 10.36 | 0.001 |
| LDL-chol (mg/dl)b | 120.30 ± 31.59 | 102.07 ± 25.32 | 0.04 |
| Triglycerides (mg/dl)b | 124.78 ± 47.70 | 63.80 ± 41.02 | 0.001 |
| hsCRP (mg/l)b | 10.19 ± 6.92 | 0.93 ± 0.76 | NS |
| GFR (ml/min)b | 96.14 ± 20.76 | 91.97 ± 16.19 | NS |
aMedian; range
bMean ± SD